CLDN10
Claudin-10
Also known as: CLD10_HUMAN, CPETRL3, OSP-L
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P78369
- Gene
- CLDN10
- Ensembl
- ENSG00000134873
- Chromosome
- 13
- Canonical length
- 228 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. The expression level of this gene is associated with recurrence of primary hepatocellular carcinoma. Six alternatively spliced transcript variants encoding different isoforms have been reported, but the transcript sequences of some variants are not determined.[provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
228 residues, UniProt reviewed canonical sequence.
>P78369|CLDN10
1 MASTASEIIA FMVSISGWVL VSSTLPTDYW KVSTIDGTVI TTATYWANLW KACVTDSTGV
61 SNCKDFPSML ALDGYIQACR GLMIAAVSLG FFGSIFALFG MKCTKVGGSD KAKAKIACLA
121 GIVFILSGLC SMTGCSLYAN KITTEFFDPL FVEQKYELGA ALFIGWAGAS LCIIGGVIFC
181 FSISDNNKTP RYTYNGATSV MSSRTKYHGG EDFKTTNPSK QFDKNAYVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLDN10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 112 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 112 nTPM
- salivary gland: 81 nTPM
- kidney: 73 nTPM
- amygdala: 38 nTPM
- cerebral cortex: 34 nTPM
- cervix: 29 nTPM
Single-cell type
- endometrial secretory cells: 851 nCPM
- proximal tubule cells: 549 nCPM
- pancreatic duct cells: 480 nCPM
- lacrimal acinar cells: 374 nCPM
- salivary acinar cells: 352 nCPM
- oocytes: 322 nCPM
Immune cell
- neutrophil: 4.1 nTPM
- eosinophil: 1.3 nTPM
- basophil: 0.4 nTPM
- memory B-cell: 0.3 nTPM
- plasmacytoid DC: 0.1 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebral cortex: 31 nTPM
- amygdala: 21 nTPM
- hippocampal formation: 19 nTPM
- basal ganglia: 16 nTPM
- hypothalamus: 16 nTPM
- thalamus: 16 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CLDN10.
Disease | AllUniProt
Conditions CLDN10 is implicated in, by any mechanism.
- HELIX syndrome (HELIX) MIM:617671
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 53 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- HELIX syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.54
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bicellular tight junction assembly
- calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules
- cell adhesion
- monoatomic ion transport
- paracellular transport
- regulation of monoatomic ion transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CLDN10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLDN10 as an antibody target. Whether an autoantibody or antibody against CLDN10 could matter depends on whether native CLDN10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLDN10 is annotated at the cell surface, where native CLDN10 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CLDN10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...